FdaApplication
ANDA 211901
Identifiers
- fda_app_no: ANDA211901
Properties
| Property | Value |
|---|---|
| applicant_name | MSN LABORATORIES PRIVATE LTD |
| application_type | ANDA |
| approval_date | 2023-07-24 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PLERIXAFOR | PLERIXAFOR | 24MG/1.2ML (20MG/ML) | SOLUTION;SUBCUTANEOUS |
1 product